Viewing Study NCT04676867


Ignite Creation Date: 2025-12-25 @ 12:36 AM
Ignite Modification Date: 2026-05-15 @ 4:17 PM
Study NCT ID: NCT04676867
Status: COMPLETED
Last Update Posted: 2022-12-07
First Post: 2020-12-17
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Effect of Dalcetrapib in Patients With Confirmed Mild to Moderate COVID-19
Sponsor: DalCor Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Covid19 View
Keywords:

Keywords

Keyword Brief Keyword Text View
None COVID-19 View
None Coronavirus disease View
None Dalcetrapib View